Sage Investigational Site — Burlington, Vermont

Sage Investigational Site is a clinical research site located in Burlington, Vermont, United States 05401.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Sage Investigational Site has participated in 2 clinical trials.

Therapeutic areas: Parkinson Disease, Cognitive Dysfunction, Super-Refractory Status Epilepticus.

Sponsors: Supernus Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sage Investigational Site?

Sage Investigational Site has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sage Investigational Site conducted?

Sage Investigational Site has 2 clinical trials on record. Their work covers Parkinson Disease, Cognitive Dysfunction, Super-Refractory Status Epilepticus.

Is Sage Investigational Site accredited by Crixeo Health?

Sage Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sage Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.